- Deadline
- Nov 9, 2026 · 10 days left
- Posted
- Aug 31, 2026
- Award size
- Not listed
- Total program funding
- $1.8M
- Expected awards
- 1
- Cost sharing
- Not required
- Funding type
- Cooperative agreement
- Category
- Health
Check this solicitation free
Grantee reads the full announcement and lists every required section, page limit, deadline, scoring criterion and compliance item. Takes about two minutes, no account needed.
About this opportunity
Applications for a 3-year extension/renewal of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) clinical trial consortium are requested to fully meet the enrollment targets, complete participant follow-up, and finalize data analysis and dissemination of study findings. This Notice of Funding Opportunity (NOFO) invites a Single Source application for the eligible organization, the Scientific and Data Research Center (SDRC) already involved in the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Consortium. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered.There is currently no standard of care for patients after hospitalization with acute kidney injury (AKI). Successful completion of the COPE-AKI study will provide key insights that are expected to directly inform improved clinical management strategies and the development of standard of care for Stage 2 and 3 AKI survivors.
Who can apply
- Other (see eligibility)
As this NOFO is a Single Source application, only the current recipient under RFA-DK-20-012 is eligible to apply under this announcement. Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Agency contact
Division of Kidney, Urologic, and Hematologic Diseases
- Reads the full solicitation and lays out every required section
- Drafts each section with you, in your words
- Checks the draft against every requirement before you submit
How to write it
All guidesMore from NIH
All NIH funding- Closes todayRFA-HG-27-011
GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)
Deadline Oct 30, 2026(0d)Up to $1.3M
- Closes todayRFA-HG-27-013
GREGoRi Innovation Projects (U01 Clinical Trial Optional)
Deadline Oct 30, 2026(0d)Up to $500K
- Closes todayRFA-HG-27-012
GREGoRi Technology Integration Center (U01, Clinical Trials Optional)
Deadline Oct 30, 2026(0d)Up to $2.3M
- Closes todayPAR-27-045
HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required)
Deadline Oct 30, 2026(0d)
- Closes in 3 daysPAR-24-280
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
Deadline Nov 2, 2026(3d)
- Closes in 3 daysPAR-24-279
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
Deadline Nov 2, 2026(3d)
Get new funding every Monday
New federal opportunities and upcoming deadlines for NIH and more, in one short email. Free, unsubscribe anytime.
Details from Grants.gov, last updated Aug 31, 2026. Deadlines and requirements can change: always confirm them in the official notice.